#6 and #7 points are hilarious when you compare them together Mozza
At #7 you stated Lithium Grade is "Completely Irrelevant" due to the fact that Lilac will produce a high purity Lithium Chloride Solution, regardless of the concentration of the feedstock brine
If you believe Lilac's claim to be true (Which it may or may not, we will have to wait and see)
Then don't you think it is better to have a 350mg/L Feedstock Brine, as Opposed to say a 210mg/L Feedstock Brine
To simply state that Grade is completely irrelevant is a stretch mate. A 210mg/L brine would require the same DLE plant to run through 70% more cycles, to obtain the same volume of Lithium chloride as opposed to a 350mg/L brine (at the same recovery rate)
That is 70% more beads, 70% more plant run time, 70% more wear and tear on equipment, 70% more processing, 70% more water abstraction and reinjection, 70% waste / byproducts to produce the same volume of end product
Which ultimately leads to a Significant Increase in OPEX. Grade is and will always be King
- Forums
- ASX - By Stock
- LKE
- Ann: Lake responds to online report
Ann: Lake responds to online report, page-522
-
-
- There are more pages in this discussion • 298 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LKE (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $66.74M |
Open | High | Low | Value | Volume |
3.8¢ | 4.1¢ | 3.8¢ | $253.9K | 6.440M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 260882 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 855041 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.040 |
12 | 1090449 | 0.039 |
33 | 2126233 | 0.038 |
20 | 2334622 | 0.037 |
27 | 1963529 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 917956 | 14 |
0.042 | 1389072 | 13 |
0.043 | 248131 | 4 |
0.044 | 1268111 | 10 |
0.045 | 1051087 | 7 |
Last trade - 14.57pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
LKE (ASX) Chart |